NYSE : ARE
Alexandria Real Estate Equities, Inc. — Key statistics
Real Estate · REIT - Office · United States
Last price 40.6 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.26B |
| Enterprise Value | 20.00B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 26, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 174.16M |
| Shares Outstanding | 174.16M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.62% |
| Owned by Institutions (%) | 89.32% |
| Float | 154.67M |
Ratios
| Measure | Value |
|---|
| Price/FFO Ratio | 4.19 |
| Price/AFFO Ratio | 5.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.56 |
| Forward PS | 2.71 |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.94 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 7.17 |
| EV / EBITDA | 11.65 |
| EV / EBIT | 40.34 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.15 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 7.66 |
| Debt / FCF | n/a |
| Interest Coverage | 1.79 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -6.25% |
| Return on Assets (ROA) | 0.86% |
| Return on Invested Capital (ROIC) | 0.92% |
| Return on Capital Employed (ROCE) | 1.48% |
| Weighted Average Cost of Capital (WACC) | 4.80% |
| Revenue Per Employee | $5.37M |
| Profits Per Employee | -$2.79M |
| Employee Count | 514 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -29.11% |
| 50-Day Moving Average | 47.85 |
| 200-Day Moving Average | 49.47 |
| Relative Strength Index (RSI) | 39.00 |
| Average Volume (20 Days) | 2,583,054 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.26M |
| Short Previous Month | 6.76M |
| Short % of Shares Out | 4.17% |
| Short % of Float | 4.69% |
| Short Ratio (days to cover) | 3.37 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.76B |
| Gross Profit | 1.87B |
| Operating Income | 490.70M |
| Pretax Income | -1.23B |
| Net Income | -1.43B |
| EBITDA | 1.70B |
| EBIT | 490.70M |
| Loss Per Share | -$8.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 508.86M |
| Total Debt | 13.25B |
| Net Cash | -12.74B |
| Net Cash Per Share | -$73.16 |
| Equity (Book Value) | 18.42B |
| Book Value Per Share | 86.67 |
| Working Capital | 1.15B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.19B |
| Capital Expenditures | -1.66B |
| Depreciation & Amortization | 1.24B |
| Net Borrowing | n/a |
| Free Cash Flow | -472.62M |
| FCF Per Share | -$2.71 |
Margins
| Measure | Value |
|---|
| Gross Margin | 67.68% |
| Operating Margin | 17.78% |
| Pretax Margin | -44.75% |
| Profit Margin | -51.81% |
| EBITDA Margin | 61.57% |
| EBIT Margin | 17.78% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.88 |
| Dividend Yield | 6.94% |
| Dividend Growth (YoY) | -45.45% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.09% |
| Shareholder Yield | 7.20% |
| Earnings Yield | -20.16% |
| FCF Yield | -6.70% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $50.21 |
| Price Target Difference | 20.52% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | -4.79% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |